A report on the clinical trial results of monoclonal antibody teprotumumab, now FDA-approved to treat thyroid eye disease. Roger Dailey M.D., says: “these data indicate that all patients completing the long-term evaluation had at least some improvement in one or more of the major outcomes under analysis.”
Via Twitter, Esther Choo, M.D., M.P.H., comments on Joe Biden’s use of two face masks to protect against COVID-19. She says: “This preserves the N95 with a cheaper mask. So you can swap out the top mask and keep using the N95. The VP is helping us conserve our precious PPE."
Esther Choo, M.D., M.P.H., speaks with MarketWatch regarding the importance of COVID-19 health care access in rural settings. She says: “Sometimespeople drive in from rural areas three hours away; it’s such a big deal for them to get in. And if they’re getting sicker, the last thing they can do is hop in a car and drive themselves back and they don’t have a family member who can bring them back.”
Bory Kea, M.D., discusses OHSU’s progress and participation in a national study looking at the benefits of convalescent plasma therapy for COVID-19 patients.
A KATU-TV campaign sponsored by Credit Unions for Kids helps fundraise for the Rood Family Pavilion. Dana Brander, M.D., Cindy McEvoy, M.D. and Carrie Phillipi, M.D., Ph.D., as well as patient Brayden, are featured.
A KATU-TV campaign sponsored by Credit Unions for Kids helps fundraise for the Rood Family Pavilion. Dana Brander, M.D., Cindy McEvoy, M.D. and Carrie Phillipi, M.D., Ph.D., as well as patient Noah are featured.
A KATU-TV campaign sponsored by Credit Unions for Kids helps fundraise for the Rood Family Pavilion. Dana Brander, M.D., Cindy McEvoy, M.D. and Carrie Phillipi, M.D., Ph.D., as well as patient Chloe are featured.